#United States #Burlington #Community Health Centers #Q2i #Substance Use Disorder

Community Health Centers Launch Groundbreaking Initiative to Combat Overdose Crisis in Vermont

In a significant move towards addressing Vermont's overdose epidemic, Community Health Centers (CHC) has introduced an innovative Incentive-Based Recovery Program, utilizing advanced contingency management (CM) technology from Q2i. This program aims to improve recovery outcomes for individuals grappling with substance use disorder, especially in light of the alarming statistics surrounding fentanyl-related deaths in the state.

Fentanyl was involved in over 93% of Vermont's fatal overdoses last year, underscoring the urgent need for effective recovery support systems. The CHC's CM initiative employs an evidence-based approach that incentivizes patients through tangible rewards, such as gift cards, for achieving key recovery milestones. These milestones include regular attendance at counseling sessions and consistent negative drug screenings. The efficacy of CM in enhancing treatment engagement, decreasing relapse rates, and promoting sustainable recovery has been well-documented, providing hope for many affected individuals.

Heather Stein, the Chief Medical Officer at CHC, emphasizes the importance of recognizing every small victory in the recovery journey. “Every step forward in recovery is a victory,” she states. “This program acknowledges those steps that often go unnoticed and provides patients with an extra boost to keep moving forward.”

The launch of this program comes at a critical juncture in Vermont’s ongoing battle against opioid addiction. According to the Vermont Department of Health, the state reported 183 opioid-related fatalities last year, marking a 22% decline from the previous year. While this signifies progress, the prevalence of fentanyl-related deaths remains a serious concern, with other substances like cocaine and xylazine also emerging in fatal overdoses.

The Contingency Management program at CHC serves as a vital component of Vermont’s comprehensive prevention and treatment landscape. By reinforcing positive behaviors and ensuring sustained engagement in care, the program is designed to empower patients, helping them navigate their recovery journey more effectively.

Funded through state grants, participants in this innovative program can earn small, redeemable rewards for achieving personalized recovery goals. These include attending scheduled therapy sessions, maintaining clean toxicology screenings, and actively engaging in tailored recovery planning. Betsy Fowler, Director of Mental Health and Substance Use Services at CHC, stresses that the essence of Contingency Management goes beyond mere rewards. “It’s about honoring the resilience and determination our patients exhibit in their recovery,” she explains. “This initiative represents another step toward providing whole-person care that integrates primary health, behavioral health, and recovery services for all individuals, irrespective of their financial resources.”

In partnership with Q2i, the CHC exemplifies how technology can effectively converge with evidence-based practices to facilitate real and lasting change within communities. Steve Jenkins, CEO of Q2i, expressed pride in aligning with CHC to introduce this proven strategy to Vermont’s residents. “When technology and evidence-based practices collaboratively work, communities can achieve meaningful progress.”

Through the strategic integration of behavioral health expertise with cutting-edge technology, this partnership endeavors to increase accessibility, boost engagement, and help a wider array of Vermonters attain enduring recovery. As CHC and Q2i continue to work hand-in-hand, the hope is that Vermont will emerge stronger in its fight against the substance use crisis, ultimately leading to a healthier future for all.

About Q2i

Q2i is an innovative digital health company focusing on developing solutions grounded in evidence-based research. Their technologies are designed to enhance clinical care outcomes, elevate patient engagement, and foster improved health results. Renowned for their leading role in technology-driven Contingency Management solutions, Q2i is committed to spearheading advancements in healthcare innovation. For additional information, visit Q2i.com.